Swiss National Bank’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-98,302
Closed -$385K 2608
2023
Q3
$385K Hold
98,302
﹤0.01% 2556
2023
Q2
$995K Buy
98,302
+3,600
+4% +$38.1K ﹤0.01% 2294
2023
Q1
$966K Buy
94,702
+7,900
+9% +$90.3K ﹤0.01% 2275
2022
Q4
$813K Buy
86,802
+2,900
+3% +$40.9K ﹤0.01% 2438
2022
Q3
$1.22M Hold
83,902
﹤0.01% 2219
2022
Q2
$1.11M Hold
83,902
﹤0.01% 2305
2022
Q1
$1.43M Buy
83,902
+34,200
+69% +$580K ﹤0.01% 2221
2021
Q4
$1.27M Buy
+49,702
New +$1.55M ﹤0.01% 2329

Other funds holding TSVT

Swiss National Bank's TSVT Position: Q4 2023 in Review

Swiss National Bank sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 98,302 shares — an estimated $385K sold.

Swiss National Bank first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $1.43M in Q1 2022. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Swiss National Bank reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Swiss National Bank sold 98,302 2seventy bio shares in Q4 2023, an estimated $385K.
  • Swiss National Bank first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • Swiss National Bank's 2seventy bio position peaked at $1.43M in Q1 2022.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.